APA (7th ed.) Citation

Gramatzki, D., Felsberg, J., Hentschel, B., Wolter, M., Schackert, G., Westphal, M., . . . Reifenberger, G. (2021). Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: Is there a link? European journal of cancer, 147, . https://doi.org/10.1016/j.ejca.2021.01.014

Chicago Style (17th ed.) Citation

Gramatzki, Dorothee, et al. "Telomerase Reverse Transcriptase Promoter Mutation- and O6-methylguanine DNA Methyltransferase Promoter Methylation-mediated Sensitivity to Temozolomide in Isocitrate Dehydrogenase-wild-type Glioblastoma: Is There a Link?" European Journal of Cancer 147 (2021). https://doi.org/10.1016/j.ejca.2021.01.014.

MLA (9th ed.) Citation

Gramatzki, Dorothee, et al. "Telomerase Reverse Transcriptase Promoter Mutation- and O6-methylguanine DNA Methyltransferase Promoter Methylation-mediated Sensitivity to Temozolomide in Isocitrate Dehydrogenase-wild-type Glioblastoma: Is There a Link?" European Journal of Cancer, vol. 147, 2021, https://doi.org/10.1016/j.ejca.2021.01.014.

Warning: These citations may not always be 100% accurate.